Shenzhen NewDEL Biotech Co., Ltd.
Development Timeline
-
Apr 2021NewDEL was founded as the first biotech company incubated by SMD.
-
July 2021
Angel round financing led by Cowin Capital
-
Apr 2022
The 1st indication of ND-003 enterred IND-enabling phase
-
Jun 2022
Pre-A round financing led by Bioching Capital and followed by Cowin Capital
-
Jul 2023
Pre A+ round financing completed
-
Aug 2023
Awarded the first prize in the Shenzhen Innovation & Entrepreneurship Competition in Yantian District
-
Jul 2023-Jan 2024
The FDA and NMPA cleared IND for ND-003 for oncology, renal fibrosis, IPF and atopic dermatitis.
Awarded China's Top 100 Sci-Tech Innovations.
-
March 2024
Series A round financing completed
Shenzhen NewDEL Biotech Co., Ltd.
Contact: Mr. Lu Email：nd@newdel.com.cn
Telephone：+86-0755-28199301 Postal code： 518110
A1503 Building 1-A YESEN Intelligent Community,1301-76 Guanguang Rd.，Longhua Dist,Shenzhen,Guangdong,China
Copyright 2021-2022深圳市新樾生物科技有限公司版权所有 粤ICP备2022125782号
